Online Formulary

Drug Status Key

On Formulary
Specialist Initiation

On formulary but requires initiation by a specialist.
GPs may then take on maintenance prescribing -
Using the Formulary (eastkentformulary.nhs.uk)
Shared Care
Hospital Only
Not Recommended

Preferences

First Line
Second Line
Third Line
No Preference

Newsletters

Please click on a month in the table below for the corresponding newsletter.

Kent & Medway Newsletters

Issues	Contents Summary
Issue 48 - July 2023	Kent and Medway position statement on Inclisiran (Leqvio®) MHRA Drug Safety Update June 2023 Medicine Recalls GLP-1 Receptor Agonist Shortage Gluten Free Prescribing in Kent and Medway NEWT guidelines subscription renewal Missed Savings Opportunity EOL medication Shortages Summary
Issue 49 - August 2023	Reducing the cost of OTC Prescriptions and freeing up Practice and Pharmacy time Vitamin B12 Prescribing in Kent and Medway Care Homes Best Practice Guidance Asthma training/engagement sessions Webinar on Lipids Management National Patient Safety Alert (NatPSA) – Potent Synthetic Opioids implicated in Heroin overdoses and deaths Adrenaline auto-injectors (AAIs) MHRA guidance MHRA Drug Safety Update August 2023 Medicine Recalls Shortages Summary NICE News August 2023
Issue 50 - September 2023	Hypomagnesaemia in Adults – New Primary Care Guidance New Oral Nutritional Supplement (ONS) Guidelines in Kent and Medway Kent and Medway Asthma Guidance Triptorelin Formulary Addition New guidelines and formulary changes for insulin pen needles, meters, test strips and lancets High strength insulin National Patient Safety Alert – Shortage of GLP-1 Receptor Agonists MHRA Drug Safety Update Shortages ADHD Medication Shortages The 16th Royal Marsden Opioid, Cannabinoid & Gabapentinoid Conference Using Skin Barriers with Sensors of Glucose Monitoring Systems
Issue 51 - October 2023	Update October 2023: Paediatric Asthma and Nebulisers Best Practice Guidance (BPG) for Care Homes Substance Misuse - Naloxone The Role of Inclisiran in Lipid Management Recommendations on the national supply disruption to ADHD medication Valproate containing products – October 2023 Drug Tariff update Pharmacists Epilepsy Education Group (PEEG) Antimicrobial Prescribing and Stewardship (APS) Competency Framework Serious Shortage Protocols for Clarithromycin MHRA Drug Safety Update – September 2023 Shortages Summary NICE News – October 2023
Issue 52 - November 2023	Kent & Medway Medicines Sustainability Re-Hale Project Direct Oral Anticoagulants (DOACs) – A Change to Improve Patient Safety Emollients and fire safety New Melatonin Guidelines in Kent and Medway Gastro-intestinal Anti-spasmodic Prescribing New Position Statement: Safe Prescribing of Injectable Medicines in Primary Care Addition of Actimorph orodispersible morphine to formularies and new Morphine Sulfate Liquid Guidance Addition of Methenamine Hippurate to the Kent and Medway Formulary Nitrofurantoin MHRA Drug Safety Update – New Supporting guidance for patients and prescribers Wegovy and risks of inadvertent prescribing and dispensing of injectable semaglutide Kent and Medway guidance on Emollient Prescribing MHRA Drug Safety Update Shortages Summary
Issue 53 - December 2023	Licensing of anastrozole for primary prevention of breast cancer Valproate: organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients New Dementia Guidelines in Kent and Medway Kent and Medway List of New Approved Guidelines NIHR Evidence Webinar 30th January 2024: How can we reduce antibiotic use in primary care? Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba) products Potential contamination of some carbomer-containing lubricating eye products with Burkholderia cenocepacia - measures to reduce patient risk MHRA Drug Safety Update NICE News December 2023 Medicine Supply Notification: Bumetanide 1mg and 5mg tablets ADHD medicines supply disruption update Shortages Summary
Issue 54 - January 2024	Antibiotic Course Length Interaction of tramadol and warfarin Pregabalin and risk in pregnancy / Gabapentinoid prescribing FreeStyle Libre 3 Kent and Medway List of New Approved Guidelines MHRA Drug Safety Update Update to the NPSA on GLP-1 RAs Shortages
Issue 55 - February 2024	Mounjaro®▼ (tirzepatide) KwikPen® solution for injection Wegovy® (semaglutide) solution for injection for Weight Management Trurapi® (insulin aspart) 100units/ml solution for injection Fezolinetant (Veoza®) – not for NHS prescribing Prescribing of Armour Thyroid and other unlicensed desiccated thyroid extract (DTE) products Gluten Free Prescribing in Kent and Medway Reducing OTC Prescriptions in Primary Care East Kent HCP – KCHFT pilot: mucolytic drug holiday initiative MHRA Press Release – Pioneering genetic biobank to start recruiting patients on stroke prevention medicines MHRA Drug Safety Update – January 2024 NICE News – February 2024 Shortages Summary Shortage of Tegretol 200mg and 400mg prolonged release tablets ADHD medication availability and supply disruption update Riluzole availability
Issue 56 - March 2024	Kent and Medway Dry Eye Guidance - updated Reducing ONS Starter Pack Prescriptions in Primary Care Prescribing of DPP-4 inhibitors (gliptins) – reminder that sitagliptin is 1st line choice Daridorexant for treating long-term insomnia Impact of C. Difficile Infections and Management Update – 2nd May 2024 LMWH Prescribing Pathways in East Kent Sharps Bin Provision - Swale Borough Council MHRA Drug Safety Update February 2024 Shortages Summary Shortage of Rasagiline 1mg tablets (March 2024)
Issue 57 - April 2024	Glaucoma – Generic prescribing Eye supplements - Lutein and Antioxidants Reminder: Eye Lid Hygiene Continence and stoma appliances - Ordering process reminder ScriptSwitch® Quantity Limit Switches PITstop diabetes on-demand videos New SPS Resource – Managing Interactions with Direct Oral Anticoagulants (DOACs) BNF Interaction Update: Tramadol – Warfarin Interaction MHRA Drug Safety Update March 2024 NICE News – April 2024 NHS England: Puberty Suppressing Hormones for Children and Adolescents with Gender Incongruence Shortages Summary ADHD medication availability and supply disruption update Discontinuations of Insulatard® InnoLet® and Levemir InnoLet® 3ml pre-filled disposable devices
Issue 58 - May 2024	Adding “Hospital/specialist” medications to a patient’s medication screen on EMIS Reminder – MHRA Drug Safety Update 19 April 2022. Pregabalin (Lyrica): findings of safety study on risks during pregnancy Kent and Medway List of New Approved Guidelines from Integrated Medicines Optimisation Committee (IMOC) April 2024 Obtaining Anticoagulant alert cards and DOAC booklets Methadone Prescribing Cost-effective Prescribing of Macrogol Oral Powder Sachets PrescQIPP Clinical Masterclass webinars UTI diagnostic quick reference tool review consultation - closes 2 June MHRA Drug Safety Update Shortages Update
Issue 59 - June 2024	Eprex to Retacrit switch - Message from East Kent Hospitals UFT for GP Practices Reminder – Ongoing GLP-1 RA Supply Issues GLP-1 RAs for Weight Management / The risks of inadvertent prescribing and dispensing of injectable semaglutide (Wegovy®& Ozempic®) EasyChamber® spacer devices MORPh webinar: SMRs & Medicines Optimisation and Sustainability in Respiratory Care Pharmacy First Reminder for East Kent Practices – Hospital Only Formulary status for Trimetazidine and Sucralfate National Patient Safety alert: Shortage of Pancreatic enzyme replacement therapy (PERT) MHRA Drug Safety Update – May 2024 NICE News – June 2024 Shortages Summary
Issue 60 - July 2024	Clozapine prescribing Assessment of a pharmacist’s ability to interpret, review, and action CYP2C19 pharmacogenetic reports and obtain pharmacist’s views on the reporting structure – Deadline 26th July 2024. Best Practice Guidance (BPG) for Care Homes National Patient Safety – Improvement Programmes TARGET Antibiotics – Prescribing in Primary Care Webinar: Paediatric antimicrobial prescribing in primary care Kent and Medway List of New Approved Guidelines MHRA Drug Safety Update Shortages summary

Please note that newsletters are archived after 12 months to avoid offering out-of-date information.